Tideglusib (NP-12, NP031112) is a selective and irreversible GSK3β inhibitor that was previously in clinical trials for Alzheimer’s disease and progressive supranuclear palsy [61,62,63]. This evidence concerns the gene GSK3B and Classical progressive supranuclear palsy.